NO179358C - Anvendelse av substituerte benzofuranylpiperidiner som nootropikum - Google Patents

Anvendelse av substituerte benzofuranylpiperidiner som nootropikum

Info

Publication number
NO179358C
NO179358C NO920591A NO920591A NO179358C NO 179358 C NO179358 C NO 179358C NO 920591 A NO920591 A NO 920591A NO 920591 A NO920591 A NO 920591A NO 179358 C NO179358 C NO 179358C
Authority
NO
Norway
Prior art keywords
nootropics
piperidines
substituted benzofuranyl
treatment
disorders
Prior art date
Application number
NO920591A
Other languages
English (en)
Norwegian (no)
Other versions
NO920591L (no
NO920591D0 (no
NO179358B (no
Inventor
Cesare Mondadori
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO920591D0 publication Critical patent/NO920591D0/no
Publication of NO920591L publication Critical patent/NO920591L/no
Publication of NO179358B publication Critical patent/NO179358B/no
Publication of NO179358C publication Critical patent/NO179358C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO920591A 1991-02-15 1992-02-14 Anvendelse av substituerte benzofuranylpiperidiner som nootropikum NO179358C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (4)

Publication Number Publication Date
NO920591D0 NO920591D0 (no) 1992-02-14
NO920591L NO920591L (no) 1992-08-17
NO179358B NO179358B (no) 1996-06-17
NO179358C true NO179358C (no) 1996-09-25

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920591A NO179358C (no) 1991-02-15 1992-02-14 Anvendelse av substituerte benzofuranylpiperidiner som nootropikum

Country Status (16)

Country Link
EP (1) EP0499586B1 (es)
JP (1) JPH0570352A (es)
KR (1) KR920016098A (es)
AT (1) ATE138805T1 (es)
AU (1) AU655227B2 (es)
CA (1) CA2061015A1 (es)
DE (1) DE59206442D1 (es)
DK (1) DK0499586T3 (es)
ES (1) ES2087497T3 (es)
GR (1) GR3020155T3 (es)
IE (1) IE74906B1 (es)
IL (1) IL100889A (es)
MX (1) MX9200620A (es)
NO (1) NO179358C (es)
NZ (1) NZ241608A (es)
ZA (1) ZA921091B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3595093A (en) * 1992-02-21 1993-09-13 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2938463B2 (ja) * 1987-10-22 1999-08-23 マサチユセツツ・インスチチユート・オブ・テクノロジー 月経前又は後期黄体期症候群の処置

Also Published As

Publication number Publication date
ZA921091B (en) 1992-09-30
EP0499586A1 (de) 1992-08-19
NO920591L (no) 1992-08-17
IE920486A1 (en) 1992-08-26
DK0499586T3 (da) 1996-06-24
NZ241608A (en) 1997-06-24
KR920016098A (ko) 1992-09-24
NO920591D0 (no) 1992-02-14
GR3020155T3 (en) 1996-09-30
IE74906B1 (en) 1997-08-13
EP0499586B1 (de) 1996-06-05
IL100889A (en) 1997-03-18
IL100889A0 (en) 1992-11-15
JPH0570352A (ja) 1993-03-23
AU1087792A (en) 1992-08-20
CA2061015A1 (en) 1992-08-16
ES2087497T3 (es) 1996-07-16
MX9200620A (es) 1992-08-01
NO179358B (no) 1996-06-17
ATE138805T1 (de) 1996-06-15
DE59206442D1 (de) 1996-07-11
AU655227B2 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
NO931056D0 (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
DK0574313T3 (da) 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
NO961687D0 (no) Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
ATE211743T1 (de) Substituierte 3-aminochinuclidine
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
FI962324A0 (fi) N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF
DK0633259T3 (da) Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
NO921609D0 (no) Sulfonamider og deres medisinske anvendelse
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
NO953967L (no) Indolderivater som 5-HT1A og/eller 5-HT2 ligander
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
NO180632C (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
FI962418A (fi) Syklisiä amidijohdannaisia neurokiniini A antagonisteina
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
NO881308L (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
NO179358C (no) Anvendelse av substituerte benzofuranylpiperidiner som nootropikum
NO307029B1 (no) Anvendelse av 4-klor-5-[(4,5-dihydro-1H-imidazol-2-yl)-amino]-6-metoksy-2-metylpyrimidin til fremstilling av farmasoytiske preparater for behandling av hyperglykemier
NO982863L (no) Nye forbindelser med analgetisk effekt
BR0016516A (pt) Pirróis substituìdos
DK0590520T3 (da) Arylsulfonamido- og sulfonamidopyridin-2-carboxyl-syreestere samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ES2001104A6 (es) Un procedimiento para la preparacion de nuevos derivados sustituidos del acido 1,4-dihidro-3,5-piridindicarboxilico.
EP0344982A3 (en) Alpha-adrenergic receptor antagonists
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister
DK286090A (da) Alfa-adrenerge receptorantagonister